Introduction: Herpes zoster is caused by the reactivation of latent varicella infection within the sensory ganglia, caused by the varicella-zoster virus (VZV). The disease is classically characterized by a painful unilateral vesicular eruption. Complications of the disease include herpes zoster ophthalmicus, Ramsay Hunt syndrome, acute retinal necrosis, and post-herpetic neuralgia. In this paper, we discuss the epidemiology, pathogenesis, clinical features, diagnosis, management, and vaccination strategies of herpes zoster and post-herpetic neuralgia. Method: This paper was developed with input from specialists from Singapore’s public sectors—dermatologists, family physicians, and infectious diseases specialists. Results: The diagnosis of herpes zoster is clinical and can be aided with laboratory investigations. Early initiation of antivirals, within 72 h of onset, can reduce the severity and duration of the condition and decrease the intensity of pain. In patients with a high risk of post-herpetic neuralgia, early initiation of anticonvulsants or tricyclic antidepressants can be considered. Herpes zoster is highly preventable, with the advent of the recombinant zoster vaccine (RZV) providing an overall vaccine efficacy of 97.2%. Procedures such as epidural blocks and subcutaneous or intracutaneous injections of local anesthetics and steroids can be considered for patients with a high risk of post-herpetic neuralgia to reduce its incidence. Conclusion: This article serves as a guideline for clinicians in the diagnosis, investigations, management, and prevention of herpes zoster. With the majority of adults in Singapore currently at risk of developing herpes zoster due to varicella immunization being only introduced in 2020, it is important for clinicians to recognize and manage herpes zoster appropriately.
Background: Vaccines have eradicated deadly diseases, yet vaccine hesitancy persists, leading to reduced uptake. Some individuals, mistrustful of healthcare providers, may turn to tools like ChatGPT for information. We evaluated ChatGPT’s responses to common vaccine hesitancy questions. Methods: Infectious disease physicians compiled 15 frequently encountered questions relating to vaccine hesitancy, focusing on concerns about efficacy, adverse effects, and cultural or religious issues, and submitted them to ChatGPT on 18 October 2023. Two independent physicians assessed the responses for factual accuracy and alignment with recommendations from the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP). Results: A representative selection of responses is shown. ChatGPT consistently provided fact-based, reassuring responses. For instance, it accurately addressed the benefits of male HPV vaccination; however, it failed to consider ACIP’s age-specific recommendations and individual sexual health factors. While correcting mRNA vaccine misconceptions, it did not mention the availability of non-mRNA COVID-19 vaccines. It also lacked depth in discussing religious objections, deferring users to faith leaders and providers. Conclusions: ChatGPT provides generally accurate information and may be a useful adjunct in addressing vaccine hesitancy. With refinement, it could complement public health efforts to improve vaccine confidence and counter misinformation.
1 September 2021 in International Journal of Infectious Diseases
Dengue fever places a substantial burden on healthcare systems in endemic areas. Traditional inpatient management places strain on hospital capacity during seasonal surges. This study evaluates an expanded nurse-led Dengue Outpatient Management (DOM) program at a tertiary centre in Singapore. A prospective observational study was conducted from January 2023 to August 2024. DOM inclusion criteria were broadened to include older adults and patients with comorbidities, if clinically stable. Patients received physician evaluation, a nurse-led symptom-based assessment and vital signs monitoring. There were 167 patients managed in DOM in the study period. The model saved an average of 3.3 bed-days per patient, amounting to approximately 231 bed-days saved in 2023. This expanded nurse-led outpatient dengue management model demonstrates safety, feasibility, and resource efficiency. With structured patient selection and monitoring protocols, DOM significantly reduces hospital bed occupancy while offering a scalable solution for dengue-endemic regions.
30 April 2026 in International Journal of Infectious Diseases
Following the COPAT randomized trial demonstrating improved safety with early outpatient oral antibiotics, we report outcomes from such a clinic in Singapore. In this observational cohort of deep-seated infections, we found that relapse of infection and oral-to-intravenous antibiotic switch were uncommon, supporting feasibility of this approach in the real-world setting.